title: Is cortisol involved in upper-body obesity?
abstract: Obesity is a major health problem that can be defined as an excess of body fat, associated with hypertension, diabetes and coronary heart disease. Several groups have evaluated the clinical significance of variations in fat cell distribution on these complications. A frequently used index of fat cell distribution is the waist to hips ratio (W/H). A high W/H ratio is said to reflect upper body fat cell distribution while a low waist to hips ratio reflects a lower body type fat cell distribution. Studies have shown that those whose W/H ratio indicate upper body fat cell distribution had a higher prevalence of diabetes and hypertension than those with the lower type. Over the years cortisol has attracted considerable interest as a possible factor in the development and maintenance of obesity. The clinical findings associated with upper body type of obesity are in many ways similar to those of the hypercortisol state. Our hypothesis is that upper body obesity forms a unique subgroup of the obese population and their regional fat distribution is associated with mild cortisol excess. In humans, studies have reported that some obese subjects hypersecrete cortisol and have an increase in the cortisol production rate. Although recent studies would tend to discount any influence of cortisol in human obesity, several factors should be taken into consideration. It is difficult to measure cortisol economy in obese subjects because among other things the measurements are less than precise; and cortisol secretion changes during the day and in response to outside stimuli. Further, obesity is a heterogeneous disorder and not all obese subjects may have the same disorder.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medicine, LSU Medical School, New Orleans 70112-2865.
authors.forename: M P
authors.initials: MP
authors.lastname: Rivera
authors.forename: F
authors.initials: F
authors.lastname: Svec
mesh_terms: D000005:Abdomen / Q000033:anatomy & histology* / Q000502:physiology; D000204:Activity Cycles / Q000502:physiology; D000273:Adipose Tissue / Q000033:anatomy & histology* / Q000166:cytology; D000308:Adrenocortical Hyperfunction / Q000150:complications; D000818:Animals; D001827:Body Height / Q000502:physiology; D015992:Body Mass Index; D001835:Body Weight / Q000502:physiology*; D002449:Cell Aggregation / Q000502:physiology; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000502:physiology*; D007328:Insulin / Q000502:physiology; D009765:Obesity / Q000209:etiology* / Q000503:physiopathology; D013909:Thorax / Q000033:anatomy & histology / Q000502:physiology
chemical_list: D007328:Insulin; D006854:Hydrocortisone